Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Origimm Biotechnology

Origimm Biotechnology?uq=x1rNslWr
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
3 INVESTORS
Description

Owner and operator of a biotech company. The company offers vaccine candidate antigens and is also involved in the development of a novel treatment against acne, based on a prototype vaccine against acne associated bacteria.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Leberstraße 20
  • Vienna, 1110
  • Austria
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Origimm Biotechnology’s full profile, request a free trial.

Origimm Biotechnology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 01-Dec-2015 Completed Startup
3. Capitalization 01-Mar-2015 Completed Startup
2. Seed Round 16-May-2014 Completed Startup
1. Accelerator/Incubator $37.3K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Origimm Biotechnology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Forschungsförderungsfonds Government 000 0000 000000 0
Austria Wirtschaftsservice Other Minority 000 0000 000000 0
INiTS Universitäres Gründerservice Accelerator/Incubator 000 0000 000000 0

Origimm Biotechnology Executive Team (3)

Name Title Board
Seat
Contact
Info
Sanja Selak Ph.D Co-Founder & Chief Executive Officer
Thomas Fischer Chief Financial Officer
Tamás Berke MD Co-Founder and Chief Operating Officer